Skip to main content

Advertisement

Figure 2 | Journal of Translational Medicine

Figure 2

From: Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients

Figure 2

Representative immunological monitoring assays detecting peptide-specific CTL response. PBLs obtained from CR patient (case 6) after the 8th vaccination were cultured with URLC10-peptide stimulation and subjected to the ELISPOT assay (a, b). The cultured lymphocytes were analyzed by flow cytometry, and proportion of URLC10 dextramer positive cells in CD8+CD3+CD4- cells were calculated (c).

Back to article page